SUmmary Status Subcommittee
The first evidence-based consensus statement on tumor immunotherapy for the treatment of patients with bladder cancer was developed by the Society for Immunotherapy of Cancer (SITC) and published online by the Journal for ImmunoTherapy of Cancer, in 2017.
Immunotherapeutic drugs approved for the treatment of bladder cancer include several checkpoint inhibitors and the immunotherapeutic vaccine, Bacillus Calmette-Guérin (BCG). This consensus statement provides expert evidence-based recommendations for the use of these immunotherapies, including recommendations for patient selection, toxicity management, clinical end points and sequencing or combination of therapies.
Published Aug. 15, 2017 in the Journal for ImmunoTherapy of Cancer (JITC) as "The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma."
Ashish Kamat, MD, MBBS, FACS (co-chair)University of Texas MD Anderson Cancer Center
Prasanth Abraham, RNUniversity of Texas MD Anderson Cancer Center
Matthew Galsky, MDTisch Cancer Institute At Mount Sinai Medical Center
Donald Lamm, MD, FACSBladder Cancer Genitourinary Oncology
Cheryl Lee, MDUniversity of Michigan
Mike O’Donnell, MDUniversity of Iowa
Daniel Petrylak, MDYale Cancer Center
Eila Skinner, MDStanford University
John Taylor III, MDUniversity of Connecticut
Jonathan Rosenberg, MD (co-chair)Memorial Sloan Kettering Cancer Center
Joaquim Bellmunt, MDDana-Farber Cancer Institute
Badri Konety, MD, MBAUniversity of Minnesota
David LanghamBladder Cancer Advocacy Network North Carolina Triangle Chapter
Matthew Milowsky, MDUniversity of North Carolina
Peter O’Donnell, MDUniversity of Chicago
Padmanee Sharma, MD, PhDUniversity of Texas MD Anderson Cancer Center
Guru Sonpavde, MDUniversity of Alabama
Key points from SITC's Cancer Immunotherapy Guidelines Bladder Carcinoma have been distilled into a Pocket Guide. This condensed, easily accessible version of the full Cancer Immunotherapy Guideline is a quick-reference tool available in both digital and print.
Download SITC's Cancer Immunotherapy Guidelines Bladder Carcinoma Pocket Guide on any desktop or mobile device free today.*
*Available only through the Guideline Central App.
ORDER Digital/Print Guide
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org